GRNQ Stock Earnings: Greenpro Capital Reported Results for Q2 2024
Greenpro Capital Q2 2024 Results: Greenpro Capital reported a second-quarter earnings per share of -7 cents and revenue of $361,174.
Automated Earnings Coverage: InvestorPlace Earnings utilizes TradeSmith data to automate the reporting of quarterly earnings, providing quick insights on key financial figures without human intervention.
Trade with 70% Backtested Accuracy
Analyst Views on GRNQ
About GRNQ
About the author

Collaboration Announcement: GreenX has signed a Memorandum of Understanding with InvestaX, a licensed security tokens investment platform in Singapore, to enhance secondary trading opportunities for security tokens and digital assets across various markets.
Integration with IX Swap: The partnership includes IX Swap, the first decentralized exchange for security token offerings, which aims to provide liquidity and bridge centralized and decentralized finance, facilitating a broader trading platform for both accredited and retail investors.
Greenpro Capital Q2 2024 Results: Greenpro Capital reported a second-quarter earnings per share of -7 cents and revenue of $361,174.
Automated Earnings Coverage: InvestorPlace Earnings utilizes TradeSmith data to automate the reporting of quarterly earnings, providing quick insights on key financial figures without human intervention.

- Top Gainers: Various stocks are experiencing significant increases in value, with companies like Gabelli Multi-Media Trust Inc. and Aditxt seeing substantial gains due to rights offerings and merger agreements.
- Top Losers: Conversely, some stocks are facing declines, such as Five Below and New Horizon Aircraft, which are dropping following CEO departures and airshow plans.
- Match Group Stock Surge: Match Group, Inc. shares rose 8% in pre-market trading after Starboard Value acquired over 6.5% stake and may push for a potential sale if performance does not improve.
- Other Pre-Market Stock Movements: Various other stocks experienced significant movements in pre-market trading, with companies like Conduit Pharmaceuticals, Meiwu Technology, AEON Biopharma, and others seeing notable changes.







